NEJM Highlights Promising Step Towards Functional Cure for Chronic Hepatitis B and New Atrial Fibrillation Treatment
The latest issue of The New England Journal of Medicine, dated October 25, 2026, features discussions on a promising development towards a functional cure for chronic hepatitis B, the use of first-line pulsed field ablation for persistent atrial fibrillation, strategies to reduce transfusion demand in surgery, and treatment for rifampicin-resistant tuberculosis.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.
Open NewsSnap.ai